Nonalcoholic steatohepatitis (NASH) is a progressive liver disease that has become a major global health concern, affecting millions. As an advanced form of nonalcoholic fatty liver disease (NAFLD), it can progress to fibrosis, cirrhosis, and liver failure. Despite its rising prevalence of NASH, managing the disease remains challenging due to the absence of FDA-approved treatments and...